Literature DB >> 6031924

Chronic oral toxicity of 1,3-butanediol.

R A Scala, O E Paynter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6031924     DOI： 10.1016/0041-008x(67)90137-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  5 in total

1.  Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate.

Authors:  Kieran Clarke; Kirill Tchabanenko; Robert Pawlosky; Emma Carter; Nicholas S Knight; Andrew J Murray; Lowri E Cochlin; M Todd King; Andrea W Wong; Ashley Roberts; Jeremy Robertson; Richard L Veech
Journal:  Regul Toxicol Pharmacol       Date:  2012-04-11       Impact factor: 3.271

Review 2.  Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester.

Authors:  Sami A Hashim; Theodore B VanItallie
Journal:  J Lipid Res       Date:  2014-03-05       Impact factor: 5.922

3.  Physiologic, Metabolic, and Toxicologic Profile of 1,3-Butanediol.

Authors:  Cameron G McCarthy; Emily W Waigi; Gagandeep Singh; Thaddaeus R Castaneda; Blair Mell; Saroj Chakraborty; Camilla F Wenceslau; Bina Joe
Journal:  J Pharmacol Exp Ther       Date:  2021-09-14       Impact factor: 4.402

Review 4.  Ketone Administration for Seizure Disorders: History and Rationale for Ketone Esters and Metabolic Alternatives.

Authors:  Angela M Poff; Jong M Rho; Dominic P D'Agostino
Journal:  Front Neurosci       Date:  2019-10-15       Impact factor: 4.677

Review 5.  Exogenous Ketones and Lactate as a Potential Therapeutic Intervention for Brain Injury and Neurodegenerative Conditions.

Authors:  Naomi Elyse Omori; Geoffrey Hubert Woo; Latt Shahril Mansor
Journal:  Front Hum Neurosci       Date:  2022-04-28       Impact factor: 3.473
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.